Glimisave MV 2 Tablet SR

Glimisave MV 2 Tablet SR is a combination medicine prescribed to people with type 2 diabetes mellitus. It brings together three active ingredients that work in harmony to control blood sugar by enhancing insulin release, reducing excess glucose production, and slowing carbohydrate absorption in the intestine.

The sustained-release design ensures that the medicine acts over a longer period, helping to maintain stable sugar levels throughout the day. It is generally taken with food to lower the risk of stomach upset, and the exact dose should be followed as recommended by the doctor.

Advantages

• Provides effective control of blood sugar in type 2 diabetes

• Lowers the chances of diabetes-related complications

• Offers extended action due to sustained release

• Targets multiple mechanisms of blood sugar control

Common side effects may include abdominal discomfort, gas, nausea, dizziness, or mild weakness. These usually settle with time, but consult your doctor if they persist.

Mode of action
This tablet combines Glimepiride, Metformin, and Voglibose. Glimepiride helps the pancreas release insulin, Metformin improves the body’s response to insulin and decreases glucose output from the liver, while Voglibose delays the breakdown and absorption of sugars from food.